Acta Med. 1999, 42: 85-88

https://doi.org/10.14712/18059694.2019.148

Minimal Residual Disease, Its Detection and Significance in Hairy-Cell Leukemia

Pavel Žáka, Ladislav Chrobáka, Karel Dědičb

aUniversity Teaching Hospital in Hradec Králové, Department of Clinical Haematology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine in Hradec Králové, The Fingerland Department of Pathology, Hradec Králové, Czech Republic

Received August 1, 1999
Accepted September 1, 1999

References

1. Bastie JN, D'Agay MF, Flandrin G et al. Hairy cell leukemia (HCL): phase II prospective study about 28 patients treated with 2-chlorodeoxyadenosin (2CdA). Br J Haematol 1994; 87(suppl 1):209-14.
2. Carbone A, Reato G, Di Celle PF et al.: Disease eradication in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Leukemia 1994; 8:2019-21.
3. Cartun R, Coles F, Pastuszak W. Utilization of monoclonal antibody L26 in the identification and configuration of B-cell lymphomas. Am J Pathol 1987; 129:415-9.
4. Catovsky D, Golde DW, Golomb HM. Meeting report. The third international workshop on hairy cell leukemia. Laguna Niguel, California 19-20 October 1989. Br J Haematol 1990; 74:378-9. <https://doi.org/10.1111/j.1365-2141.1990.tb02606.x>
5. Catovsky D, Pettit JE, Galton DA et al. Leukemia reticuloendoteliosis ("hairy cell leukemia") a distinct clinico-pathologic entity. Br J Haematol 1974; 26:9-27. <https://doi.org/10.1111/j.1365-2141.1974.tb00445.x>
6. Di Celle PF, Reato G, Raspadori D, et al.: Molecular evaluation of clonal remission in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Leukemia Lymph 1994; 14(Suppl 1):139-42.
7. Ellison DJ, Sharpe RW, Robbins BA et al. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosin for hairy cell leukemia. Blood 1994; 84:4310-15.
8. Falini B, Pileri A, Fleghi L et al. Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow in interferon - treated hairy cell leukemia patients. Br J Haematol 1990; 76:460-8.
9. Filleul B, Delannoy A, Ferrant A et al. A single course od 2-chlorodeosyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia 1994; 8:1253-6.
10. Flandrin G, Sigaux F, Castaignes S et al.: Leucémie à tricholeucocytes: étude de l'évolution de 211 cas. Presse Méd 1984; 13:2795-9.
11. Golomb HM, Wardiman JW. Response to splenectomy in 65 patients with hairy cell leukemia: An evaluation of spleen weight and bone marrow involvement. Blood 1993; 61:349-52.
12. Hakimian D, Tallman MS, Kiley C et al. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 1993; 82:1798-802.
13. Hounieu H, Chita S, Al Saati T et al. Hairy cell leukemia. Diagnosis of bone marrow involvement in paraffin - embedded sections with monoclonal antibody DBA.44. Am J Clin Pathol 1992; 98:26-33.
14. Chrobák L. Leukemie s vlasatými buňkami. Galén: Praha, 1999.
15. Chrobák L, Podzimek K, Kerekeš Z et al. Long-term results in hairy cell leukemia treated by splenectomy. Neoplasma 1993; 40:133-6.
16. Jansen J, Hermans J, Remme J et al. Hairy cell leukemia. Clinical features and effect of splenectomy. Scand J Haematol 1978; 21:60-71. <https://doi.org/10.1111/j.1600-0609.1978.tb02495.x>
17. Jansen J, Schutt HRE, van Zwett ThL et al. Hairy cell leukemia. A B-lymphocytic disorder. Br J Haematol 1979; 42:321-30. <https://doi.org/10.1111/j.1365-2141.1979.tb03694.x>
18. Konwalinka G, Schirmer M, Hilbe W et al. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine. Blood Cells Mol Dis 1995; 21:142-51. <https://doi.org/10.1006/bcmd.1995.0016>
19. Matutes E, Meeus D, Mc Lennan K et al. The significance of minimal residual disease in hairy cell leukemia treated with deoxycoformycin: a long term followup study. Br J Haematol 1997; 98:375-83. <https://doi.org/10.1046/j.1365-2141.1997.2273044.x>
20. Piro LD, Carrera CJ, Carson DA. Lasting remission in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N Engl J Med 1990; 322:1117-21. <https://doi.org/10.1056/NEJM199004193221605>
21. Pulford KAF, Falini B, Heryet A et al. 4KB5, a new monoclonal anti-B cell antibody for the routine diagnosis of lymphoid tissue biopsies. Leukocyte Typing III, 1998; ed. by Mc Michael A.J. et al.: 828 Oxford University Press.
22. Quesada JR, Manning JT, Hersh EM et al. Alfa interferon for induction of remission in hairy cell leukemia. N Engl J Med 1984; 310:15-8. <https://doi.org/10.1056/NEJM198401053100104>
23. Spiers ASD, Parekh SJ, Bishop MB et al. Hairy-cell leukemia induction of comlete remission with pentostatin (2-deoxykoformicin). J Clin Oncol 1984; 2:1336-42. <https://doi.org/10.1200/JCO.1984.2.12.1336>
24. Thaler J, Dietze O, Faber V et al. Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha2-interferon and deoxykoformycin. Leukemia Res 1989; 13:377-82. <https://doi.org/10.1016/0145-2126(89)90077-5>
25. Visser L, Shaw A, Slupsky J et al. Monoclonal antibodies reactive with hairy cell leukemia. Blood 1989; 74:320-25.
26. Wheaton S, Tallman MS, Hakimian D et al. Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Blood 1996; 87:1556-60.
27. Žák P, Dědič K, Chrobák L. The bone marow content of DBA.44 - positive hairy cells in patients with hairy cell leukemia (HCL) in clinical hematological remission. Haematologica 1999; 84:24.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive